Angiotensin II type 1 receptor-dependent nuclear factor-κB activation-mediated proinflammatory actions in a rat model of obstructive acute pancreatitis

Journal of Pharmacology and Experimental Therapeutics

Volumn 323, Issue 1, 2007, Pages 10-18

  Yuk, Cheung Chan ^a   Po, Sing Leung ^a  

^a and Hong Kong Branch of CAS Center for Excellence in Animal Evolution and Genetics   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

3 NITROTYROSINE; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANGIOTENSIN II; ANGIOTENSINOGEN; CYCLOOXYGENASE 2; GLUTATHIONE; I KAPPA B ALPHA; I KAPPA B BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1; INTERLEUKIN 6; LOSARTAN; MYELOPEROXIDASE; PROTEIN P22; PROTEIN P67; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; TRANSCRIPTION FACTOR RELA;

ACUTE PANCREATITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOSE RESPONSE; DRUG MECHANISM; ENZYME ACTIVITY; INFLAMMATION; MALE; NONHUMAN; OXIDATIVE STRESS; PANCREAS INJURY; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ACUTE DISEASE; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; DISEASE MODELS, ANIMAL; INFLAMMATION; LOSARTAN; MALE; NF-KAPPA B; PANCREAS; PANCREATITIS; PROTEIN SUBUNITS; RATS; RATS, WISTAR; REACTIVE OXYGEN SPECIES; RECEPTOR, ANGIOTENSIN, TYPE 1;

EID: 34548826277     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.107.124891     Document Type: Article

References (38)

1. Altavilla D, Famulari C, Passaniti M, Campo GM, Macri A, Seminara P, Marini H, Calo M, Santamaria LB, Bono D, et al. (2003) Lipid peroxidation inhibition reduces NF-kappaB activation and attenuates cerulein-induced pancreatitis. Free Radic Res 37:425-435.
2. Babior BM (1999) NADPH oxidase: an update. Blood 93:1464-1476.
3. Barlas A, Cevik H, Arbak S, Bangir D, Sener G, Yegen C, and Yegen BC (2004) Melatonin protects against pancreaticobiliary inflammation and associated remote organ injury in rats: role of neutrophils. J Pineal Res 37:267-275.
4. Bataller R, Gabele E, Parsons CJ, Morris T, Yang L, Schoonhoven R, Brenner DA, and Rippe RA (2005) Systemic infusion of angiotensin II exacerbates liver fibrosis in bile duct-ligated rats. Hepatology 41:1046-1055.
5. Browatzki M, Larsen D, Pfeiffer CA, Gehrke SG, Schmidt J, Kranzhofer A, Katus HA, and Kranzhofer R (2005) Angiotensin II stimulates matrix metalloproteinase secretion in human vascular smooth muscle cells via nuclear factor-kappaB and activator protein 1 in a redox-sensitive manner. J Vasc Res 42:415-4123.
6. Chan YC and Leung PS (2006) AT1 receptor antagonism ameliorates acute pancreatitis-associated pulmonary injury. Regul Pept 134:46-53.
7. Chan YC and Leung PS (2007) Acute pancreatitis: animal models and recent advances in basic research. Pancreas 34:1-14.
8. Chen K, Chen J, Li D, Zhang X, and Mehta JL (2004) Angiotensin II regulation of collagen type I expression in cardiac fibroblasts: modulation by PPAR-gamma ligand pioglitazone. Hypertension 44:655-661.
9. Dandona P, Kumar V, Aljada A, Ghanim H, Syed T, Hofmayer D, Mohanty P, Tripathy D, and Garg R (2003) Angiotensin II receptor blocker valsartan suppresses reactive oxygen species generation in leukocytes, nuclear factor-B, in mononuclear cells of normal subjects: evidence of an anti-inflammatory action. J Clin Endocrinol Metab 88:4496-4501.
10. El Bekay R, Alvarez M, Monteseirin J, Alba G, Chacon P, Vega A, Martin-Nieto J, Jimenez J, Pintado E, Bedoya FJ, et al. (2003) Oxidative stress is a critical mediator of the angiotensin II signal in human neutrophils: involvement of mitogen-activated protein kinase, calcineurin, and the transcription factor NF-kappaB. Blood 102:662-671.
11. Flohé L, Brigelius-Flohé R, Saliou C, Traber MG, and Packer L (1997) Redox regulation of NF-kappa B activation. Free Radic Biol Med 22:1115-1126.
12. Griendling KK, Minieri CA, Ollerenshaw JD, and Alexander RW (1994) Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res 74:1141-1148.
13. Griendling KK, Sorescu D, and Ushio-Fukai M (2000) NAD(P)H oxidase: role in cardiovascular biology and disease. Circ Res 86:494-501.
14. Gukovsky I, Gukovskaya AS, Blinman TA, Zaninovic V, and Pandol SJ (1998) Early NF-kappaB activation is associated with hormone-induced pancreatitis. Am J Physiol 275:G1402-G414.
15. Han Y and Brasier AR (1997) Mechanism for biphasic rel A. NF-κB1 nuclear translocation in tumor necrosis factor α-stimulated hepatocytes. J Biol Chem 272:9825-9832.
16. Ip SP, Tsang SW, Wong TP, Che CT, and Leung PS (2003) Saralasin, a nonspecific angiotensin II receptor antagonist, attenuates oxidative stress and tissue injury in cerulein-induced acute pancreatitis. Pancreas 26:224-229.
17. Johar S, Cave AC, Narayanapanicker A, Grieve DJ, and Shah AM (2006) Aldosterone mediates angiotensin II-induced interstitial cardiac fibrosis via a Nox2-containing NADPH oxidase. FASEB J 20:1546-1548.
18. Krämer C, Sunkomat J, Witte J, Luchtefeld M, Walden M, Schmidt B, Tsikas D, Böger RH, Forssmann WG, Drexler H, et al. (2002) Angiotensin II receptor-independent antiinflammatory and antiaggregatory properties of losartan: role of the active metabolite EXP3179. Circ Res 90:770-776.
19. Leung PS, Chan WP, Wong TP, and Sernia C (1999) Expression and localization of the renin-angiotensin system in the pancreas. J Endocrinol 160:13-19.
20. Liu HQ, Wei XB, Sun R, Cai YW, Lou HY, Wang JW, Chen AF, and Zhang XM (2006) Angiotensin II stimulates intercellular adhesion molecule-1 via an AT1 receptor/nuclear factor-kappaB pathway in brain microvascular endothelial cells. Life Sci 78:1293-1298.
21. Marshall TG, Lee RE, and Marshall FE (2006) Common angiotensin receptor blockers may directly modulate the immune system via VDR, PPAR and CCR2b. Theor Biol Med Model 3:1.
22. Mori T and Cowley AW Jr (2004) Role of pressure in angiotensin II-induced renal injury: chronic servo-control of renal perfusion pressure in rats. Hypertension 43:752-759.
23. Nathan JD, Peng RY, Wang Y, McVey DC, Vigna SR, and Liddle RA (2002) Primary sensory neurons: a common final pathway for inflammation in experimental pancreatitis in rats. Am J Physiol Gastrointest Liver Physiol 283:G938-G946.
24. Rajagopalan S, Kurz S, Munzel T, Tarpey M, Freeman BA, Griendling KK, and Harrison DG (1996) Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation: contribution to alterations of vasomotor tone. J Clin Invest 97:1916-1923.
25. Ramudo L, Manso MA, Sevillano S, and de Dios I (2005) Kinetic study of TNF-alpha production and its regulatory mechanisms in acinar cells during acute pancreatitis induced by bile-pancreatic duct obstruction. J Pathol 206:9-16.
26. Sadoshima J (2002) Novel AT(1) receptor-independent functions of losartan. Circ Res 90:754-766.
27. Schupp M, Lee LD, Frost N, Umbreen S, Schmidt B, Unger T, and Kintscher U (2006) Regulation of peroxisome proliferator-activated receptor gamma activity by losartan metabolites. Hypertension 47:586-599.
28. Skurk T, van Harmelen V, and Hauner H (2004) Angiotensin II stimulates the release of interleukin-6 and interleukin-8 from cultured human adipocytes by activation of NF-kappaB. Arterioscler Thromb Vasc Biol 24:1199-1203.
29. Song AM, Bhagat L, Singh VP, Van Acker GG, Steer ML, and Saluja AK (2002) Inhibition of cyclooxygenase-2 ameliorates the severity of pancreatitis and associated lung injury. Am J Physiol Gastrointest Liver Physiol 283:G1166-G1174.
30. Suzuki Y, Lopez-Franco O, Gomez-Garre D, Tejera N, Gomez-Guerrero C, Sugaya T, Bernal R, Blanco J, Ortega L, and Egido J (2001) Renal tubulointerstitial damage caused by persistent proteinuria is attenuated in AT1-deficient mice: role of endothelin-1. Am J Pathol 159:1895-1904.
31. Thompson JE, Phillips RJ, Erdjument-Bromage H, Tempst P, and Ghosh S (1995) I kappa B-beta regulates the persistent response in a biphasic activation of NF-kappa B. Cell 80:573-582.
32. Tsang SW, Cheng CH, and Leung PS (2004a) The role of the pancreatic renin-angiotensin system in acinar digestive enzyme secretion and in acute pancreatitis. Regul Pept 119:213-219.
33. Tsang SW, Ip SP, and Leung PS (2004b) Prophylactic and therapeutic treatments with AT1 and AT2 receptor antagonists and their effects on changes in the severity of pancreatitis. Int J Biochem Cell Biol 36:330-339.
34. Tsang SW, Ip SP, Wong TP, Che CT, and Leung PS (2003) Differential effects of saralasin and ramiprilat, the inhibitors of renin-angiotensin system, on cerulein-induced acute pancreatitis. Regul Pept 111:47-53.
35. UK Working Party on Acute Pancreatitis (2005) UK guidelines for the management of acute pancreatitis. Gut 54 (Suppl 3):1-9.
36. Vaquero E, Gukovsky I, Zaninovic V, Gukovskaya AS, and Pandol SJ (2001) Localized pancreatic NF-kappaB activation and inflammatory response in taurocholate-induced pancreatitis. Am J Physiol Gastrointest Liver Physiol 280:G1197-G1208.
37. Yu JH, Lim JW, Kim H, and Kim KH (2005) NADPH oxidase mediates interleukin-6 expression in cerulein-stimulated pancreatic acinar cells. Int J Biochem Cell Biol 37:1458-1469.
38. Zaninovic V, Gukovskaya AS, Gukovsky I, Mouria M, and Pandol SJ (2000) Cerulein upregulates ICAM-1 in pancreatic acinar cells, which mediates neutrophil adhesion to these cells. Am J Physiol Gastrointest Liver Physiol 279:G666-G676.